small molecule therapeutic (Benxi Ruishengkang Pharmaceutical)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesmall molecule therapeutic (Benxi Ruishengkang Pharmaceutical)
Drug Alias Nameruizotinibruizuotini
ClassificationSmall molecules
Mechanisms of ActionProtein-tyrosine kinases inhibitorsAnticancer protein kinase inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBenxi Ruisheng Kang Pharmaceutical R & D Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBenxi Ruisheng Kang Pharmaceutical R & D Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A